CARE Ratings revealed its audited financial results for the fiscal year ending March 31, 2026, reporting consolidated revenue of ₹473.07 crore and a net profit of ₹173.70 crore.
Shareholder Returns and Governance Actions
The company's Board of Directors met on May 13, 2026, to approve these results. A key recommendation from the board was a final dividend of ₹14 per equity share for FY26, which will be put forward for shareholder approval at the upcoming Annual General Meeting (AGM).
Further governance decisions included proposing the re-appointment of BSR & Co. LLP as the Statutory Auditors for a five-year term. The company also approved the grant of 55,000 stock options to employees under its 'CARE Employee Stock Option Scheme 2020', intended to align employee incentives with long-term business performance.
Subsidiary Stake Sale Status
Discussions concerning the stake sale in its subsidiary, CareEdge Global IFSC Limited, are continuing but have experienced delays. The original timeline for this strategic divestment is now extended, with further updates anticipated.
Market Position and Competition
CARE Ratings operates as a significant credit rating agency in India. It competes within a landscape that includes other major rating firms such as CRISIL Limited, known for its wide array of financial services, and ICRA Limited, another well-established agency.
Financial Performance Comparison (FY26 vs FY25)
- Consolidated Revenue from Operations: ₹473.07 crore (FY26) versus ₹475.42 crore (FY25).
- Consolidated Net Profit: ₹173.70 crore (FY26) versus ₹179.73 crore (FY25).
Upcoming Shareholder Votes and Events
Shareholders will vote on the proposed re-appointment of BSR & Co. LLP at the upcoming 33rd Annual General Meeting, scheduled for July 3, 2026. Investors will also be closely watching for any progress or resolution regarding the delayed stake sale talks for CareEdge Global IFSC Limited.
